IM Cannabis Corp. (IMCC)
NASDAQ: IMCC · IEX Real-Time Price · USD
0.440
-0.007 (-1.65%)
At close: Jul 2, 2024, 3:55 PM
0.447
+0.007 (1.59%)
After-hours: Jul 2, 2024, 7:14 PM EDT
Company Description
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany.
It offers medical cannabis dried flowers; and full-spectrum, strain-specific cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands.
The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.
IM Cannabis Corp.
| Country | Israel |
| Founded | 1980 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 95 |
| CEO | Oren Shuster |
Contact Details
Address: 1 Adelaide Street East, Unit 801 Toronto, A6 M5C 2V9 Ontario, Canada | |
| Phone | 416-256-4202 |
| Website | imcannabis.com |
Stock Details
| Ticker Symbol | IMCC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| CIK Code | 0001792030 |
| CUSIP Number | 44969Q208 |
| ISIN Number | CA44969Q3070 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Richard Balla | Chief Executive Officer of Adjupharm |
| Oren Shuster | Chief Executive Officer and Director |
| Marc Lustig M.B.A., M.Sc. | Executive Chairman |
| Uri Birenberg | Chief Financial Officer |
| Advocate Michal Lebovitz Nissimov | General Counsel |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 6, 2024 | 6-K | Report of foreign issuer |
| Jun 5, 2024 | 6-K | Report of foreign issuer |
| May 29, 2024 | 6-K | Report of foreign issuer |
| May 8, 2024 | 6-K | Report of foreign issuer |
| May 6, 2024 | 6-K | Report of foreign issuer |
| May 1, 2024 | 6-K | Report of foreign issuer |
| Apr 16, 2024 | 6-K | Report of foreign issuer |
| Apr 9, 2024 | 6-K | Report of foreign issuer |
| Apr 4, 2024 | 6-K | Report of foreign issuer |
| Apr 4, 2024 | 6-K | Report of foreign issuer |